Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modeling the crosstalk between malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities. | Front Immunol | 2023 | 38022603 | PubTator, text mining | PubMed |
| A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients. | Front Immunol | 2023 | 38022536 | PubTator, text mining | PubMed |
| A Systematic Immune and Prognostic Analysis of CD48 Interaction with Tumor Microenvironment in Pan-Cancer. | Int J Gen Med | 2023 | 38021043 | PubTator, text mining | PubMed |
| Identification of lactylation gene CALML5 and its correlated lncRNAs in cutaneous melanoma by machine learning. | Medicine (Baltimore) | 2023 | 38013352 | PubTator, text mining | PubMed |
| Crosstalk between copper homeostasis and cuproptosis reveals a lncRNA signature to prognosis prediction, immunotherapy personalization, and agent selection for patients with lung adenocarcinoma. | Aging (Albany NY) | 2023 | 38011277 | PubTator, text mining | PubMed |
| Tumor Tropism of DNA Viruses for Oncolytic Virotherapy. | Viruses | 2023 | 38005938 | PubTator, text mining | PubMed |
| The Interplay of Genital Herpes with Cellular Processes: A Pathogenesis and Therapeutic Perspective. | Viruses | 2023 | 38005873 | PubTator, text mining | PubMed |
| ZNF643/ZFP69B Exerts Oncogenic Properties and Associates with Cell Adhesion and Immune Processes. | Int J Mol Sci | 2023 | 38003570 | PubTator, text mining | PubMed |
| Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches. | Cancers (Basel) | 2023 | 38001644 | PubTator, text mining | PubMed |
| Future prospects in radiation oncology from the perspective of innovative radiation biology. | Strahlenther Onkol | 2023 | 38001382 | PubTator, text mining | PubMed |
| Construction and evaluation of a novel prognostic risk model of aging-related genes in bladder cancer. | Curr Urol | 2023 | 37994343 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations. | Hematol Rep | 2023 | 37987319 | PubTator, text mining | PubMed |
| The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer. | Mol Cancer | 2023 | 37980528 | PubTator, text mining | PubMed |
| Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk. | Immun Ageing | 2023 | 37978401 | PubTator, text mining | PubMed |
| A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance. | Transl Cancer Res | 2023 | 37969398 | PubTator, text mining | PubMed |
| A sialyltransferases-related gene signature serves as a potential predictor of prognosis and therapeutic response for bladder cancer. | Eur J Med Res | 2023 | 37968767 | PubTator, text mining | PubMed |
| Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction. | Medicine (Baltimore) | 2023 | 37960805 | PubTator, text mining | PubMed |
| Viral and host mediators of non-suppressible HIV-1 viremia. | Nat Med | 2023 | 37957382 | PubTator, text mining | PubMed |
| Allosteric regulation of kinase activity in living cells. | Elife | 2023 | 37943025 | PubTator, text mining | PubMed |
| Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistance. | Sci Rep | 2023 | 37932473 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=17